Severe COVID-19 infection: An institutional review and literature overview

被引:0
|
作者
Akpoviroro, Ogheneyoma [1 ]
Sauers, Nathan Kyle [2 ]
Uwandu, Queeneth [1 ]
Castagne, Myriam [3 ]
Akpoviroro, Oghenetejiro Princess [4 ]
Humayun, Sara [1 ]
Mirza, Wasique [1 ]
Woodard, Jameson [1 ]
机构
[1] Geisinger Wyoming Valley Med Ctr, Dept Internal Med, Wilkes Barre, PA 18711 USA
[2] Penn State Univ, Dept Engn, State Coll, PA USA
[3] Boston Univ, Clin & Translat Sci Inst, Boston, MA USA
[4] Mater Dei Hosp, Dept Med, Msida, Malta
来源
PLOS ONE | 2024年 / 19卷 / 08期
关键词
ANGIOTENSIN-CONVERTING ENZYME; INVASIVE MECHANICAL VENTILATION; CONGESTIVE-HEART-FAILURE; OBSTRUCTIVE SLEEP-APNEA; CLINICAL CHARACTERISTICS; HOSPITALIZED-PATIENTS; SARS CORONAVIRUS; UNITED-STATES; LIVER-INJURY; AZITHROMYCIN;
D O I
10.1371/journal.pone.0304960
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Our study aimed to describe the group of severe COVID-19 patients at an institutional level, and determine factors associated with different outcomes. Methods A retrospective chart review of patients admitted with severe acute hypoxic respiratory failure due to COVID-19 infection. Based on outcomes, we categorized 3 groups of severe COVID-19: (1) Favorable outcome: progressive care unit admission and discharge (2) Intermediate outcome: ICU care (3) Poor outcome: in-hospital mortality. Results Eighty-nine patients met our inclusion criteria; 42.7% were female. The average age was 59.7 (standard deviation (SD):13.7). Most of the population were Caucasian (95.5%) and non-Hispanic (91.0%). Age, sex, race, and ethnicity were similar between outcome groups. Medicare and Medicaid patients accounted for 62.9%. The average BMI was 33.5 (SD:8.2). Moderate comorbidity was observed, with an average Charlson Comorbidity index (CCI) of 3.8 (SD:2.6). There were no differences in the average CCI between groups(p = 0.291). Many patients (67.4%) had hypertension, diabetes (42.7%) and chronic lung disease (32.6%). A statistical difference was found when chronic lung disease was evaluated; p = 0.002. The prevalence of chronic lung disease was 19.6%, 27.8%, and 40% in the favorable, intermediate, and poor outcome groups, respectively. Smoking history was associated with poor outcomes (p = 0.04). Only 7.9% were fully vaccinated. Almost half (46.1%) were intubated and mechanically ventilated. Patients spent an average of 12.1 days ventilated (SD:8.5), with an average of 6.0 days from admission to ventilation (SD:5.1). The intermediate group had a shorter average interval from admission to ventilator (77.2 hours, SD:67.6), than the poor group (212.8 hours, SD:126.8); (p = 0.001). The presence of bacterial pneumonia was greatest in the intermediate group (72.2%), compared to the favorable group (17.4%), and the poor group (56%); this was significant (p<0.0001). In-hospital mortality was seen in 28.1%. Conclusion Most patients were male, obese, had moderate-level comorbidity, a history of tobacco abuse, and government-funded insurance. Nearly 50% required mechanical ventilation, and about 28% died during hospitalization. Bacterial pneumonia was most prevalent in intubated groups. Patients who were intubated with a good outcome were intubated earlier during their hospital course, with an average difference of 135.6 hours. A history of cigarette smoking and chronic lung disease were associated with poor outcomes.
引用
收藏
页数:34
相关论文
共 50 条
  • [21] Thrombotic risk in children with COVID-19 infection: A systematic review of the literature
    Zaffanello, Marco
    Piacentini, Giorgio
    Nosetti, Luana
    Ganzarolli, Stefania
    Franchini, Massimo
    THROMBOSIS RESEARCH, 2021, 205 : 92 - 98
  • [22] Vascular Alterations Following COVID-19 Infection: A Comprehensive Literature Review
    Karakasis, Paschalis
    Nasoufidou, Athina
    Sagris, Marios
    Fragakis, Nikolaos
    Tsioufis, Konstantinos
    LIFE-BASEL, 2024, 14 (05):
  • [23] Rhabdomyolysis after COVID-19 Infection: A Case Report and Review of the Literature
    Bawor, Monica
    Sairam, Shwetha
    Rozewicz, Rachel
    Viegas, Stuart
    Comninos, Alexander N.
    Abbara, Ali
    VIRUSES-BASEL, 2022, 14 (10):
  • [24] Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature
    Rosen, Melissa H.
    Axelrad, Jordan
    Hudesman, David
    Rubin, David T.
    Chang, Shannon
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (07) : 971 - 973
  • [25] Metformin use and risk for COVID-19 infection and severe COVID-19 outcomes
    Dublin, Sascha
    Kuntz, Jennifer
    Floyd, James
    Walker, Rod
    Fortmann, Stephen
    Bayliss, Elizabeth
    Shortreed, Susan
    Harrington, Laura
    Lee, Mi
    Albertson-Junkans, Ladia
    Powers, John
    Fuller, Sharon
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 506 - 506
  • [26] Diabetes severity and the risks of COVID-19 infection and severe COVID-19 outcomes
    Dublin, Sascha
    Floyd, James
    Walker, Rod
    Kuntz, Jennifer
    Shortreed, Susan
    Fortmann, Stephen
    Bayliss, Elizabeth
    Harrington, Laura
    Fuller, Sharon
    Albertson-Junkans, Ladia
    Powers, John
    Lee, Mi
    Temposky, Lisa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 40 - 40
  • [28] COVID-19 and myocarditis: a review of literature
    Mohammed Ali
    Haaris A. Shiwani
    Mohammed Y. Elfaki
    Moaz Hamid
    Rebabonye Pharithi
    Rene Kamgang
    Christian BinounA Egom
    Jean Louis Essame Oyono
    Emmanuel Eroume-A Egom
    The Egyptian Heart Journal, 74
  • [29] A literature review of the economics of COVID-19
    Brodeur, Abel
    Gray, David
    Islam, Anik
    Bhuiyan, Suraiya
    JOURNAL OF ECONOMIC SURVEYS, 2021, 35 (04) : 1007 - 1044
  • [30] Severe Thrombocytopenia as a Manifestation of COVID-19 Infection
    Mocan, Mihaela
    Chiorescu, Roxana Mihaela
    Tirnovan, Andrada
    Buksa, Botond Sandor
    Farcas, Anca Daniela
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)